Tower Research Capital LLC (Trc) Omeros Corp Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Omeros Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,495 shares of OMER stock, worth $25,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,495

Previous 11,692 78.66%

Holding current value

$25,723

Previous $47,000 80.85%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.54 - $5.47 $32,557 - $50,307	-9,197 Reduced 78.66%	2,495 $9,000
Q2 2024 Aug 13, 2024	BUY	$3.04 - $4.23 $34,391 - $47,853	11,313 Added 2984.96%	11,692 $47,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.89 $22,147 - $37,604	-7,690 Reduced 95.3%	379 $1,000
Q4 2023 Feb 13, 2024	BUY	$1.08 - $3.63 $5,808 - $19,522	5,378 Added 199.85%	8,069 $26,000
Q3 2023 Nov 14, 2023	SELL	$2.81 - $5.69 $5,639 - $11,419	-2,007 Reduced 42.72%	2,691 $7,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $7.57 $1,054 - $1,794	237 Added 5.31%	4,698 $25,000
Q1 2023 May 09, 2023	BUY	$2.48 - $5.22 $1,106 - $2,328	446 Added 11.11%	4,461 $20,000
Q4 2022 Feb 10, 2023	SELL	$1.75 - $3.96 $3,837 - $8,684	-2,193 Reduced 35.33%	4,015 $9,000
Q3 2022 Nov 10, 2022	SELL	$3.09 - $7.46 $61,942 - $149,543	-20,046 Reduced 76.35%	6,208 $19,000
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $46,183 - $151,059	24,054 Added 1093.36%	26,254 $73,000
Q1 2022 May 12, 2022	SELL	$5.07 - $7.2 $35,266 - $50,083	-6,956 Reduced 75.97%	2,200 $14,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $19,448 - $29,292	3,430 Added 59.9%	9,156 $58,000
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $1,567 - $1,907	-117 Reduced 2.0%	5,726 $79,000
Q2 2021 Aug 16, 2021	SELL	$14.81 - $19.13 $83,839 - $108,294	-5,661 Reduced 49.21%	5,843 $87,000
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $136,052 - $220,476	9,370 Added 439.08%	11,504 $205,000
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $321,255 - $481,249	-31,682 Reduced 93.69%	2,134 $30,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $251,911 - $561,206	26,323 Added 351.3%	33,816 $342,000
Q2 2020 Aug 13, 2020	BUY	$12.21 - $16.99 $91,489 - $127,306	7,493 New	7,493 $110,000
Q3 2019 Nov 05, 2019	SELL	$14.55 - $20.56 $3,331 - $4,708	-229 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$15.0 - $19.62 $1,035 - $1,353	-69 Reduced 23.15%	229 $4,000
Q1 2019 May 14, 2019	SELL	$11.65 - $17.72 $17,242 - $26,225	-1,480 Reduced 83.24%	298 $5,000
Q4 2018 Feb 14, 2019	BUY	$10.72 - $16.73 $19,060 - $29,745	1,778 New	1,778 $20,000
Q4 2017 Feb 09, 2018	SELL	$13.26 - $22.86 $61,592 - $106,184	-4,645 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $91,785 - $115,660	4,645	4,645 $100,000

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $647M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Omeros Corp Transaction History